Meet the team


Meet the team


Nandi Proteins’ core team of senior executives is:
Neil Crabb – Executive Chairman 

lydiaChief Executive of Frontier IP Neil Crabb works closely with the Nandi team and frequently attends key meetings with partners.


Neil co-founded Sigma Capital Group plc and has considerable experience as an investor and director of a wide range of technology and university spin-out companies.


He was previously an investment manager at Duncan Lawrie Ltd and Equitable Life Assurance Soc. Neil is an approved person under the Financial Services Market Act.




Dr Lydia Campbell – Chief Technical Officer


IPLydia holds a PhD in Biochemistry from the University of Witwatersrand, South Africa and has completed a post-doctoral study in protein chemistry.


Lydia has extensive R&D and product application experience gained during 9 years with Nestle Switzerland, Germany and South Africa. She was latterly project leader in charge of culinary product development and has filed several different patents.


During her career, Lydia was also the Product Development Co-ordinator at the Dutch Blood Transfusion Service. Since 2000 she has been a part time lecturer and research leader in Food Science at Heriot-Watt University in Edinburgh.



Jim Fish – Finance Director


Jim is Finance Director and Company Secretary of Frontier IP. He has over 25 years’ experience in senior financial positions and a wide range of commercial experience including venture capital funded small/medium-sized enterprises and start-up companies.


He was latterly interim Finance Director at The One Place Capital Limited, an online technology start-up. He qualified as a chartered accountant with KPMG and holds a degree in Accounting and Finance from Heriot Watt University, Edinburgh.






David Cairns – Portfolio Director

David is Portfolio Director at Frontier IP and is responsible for developing and managing its equity and licensing portfolio. David has 25 years’ experience in developing technology from concept through to commercialisation.


He previously worked for Optos plc, the retinal imaging company, where he was instrumental in building the business from start-up, serving on the board until its flotation on the London Stock Exchange.